Frontlight ResearchEarly access
Trial site
START Barcelona Hospital HM Nou Delfos
- 5running trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Liver and biliary tract cancer3 trials
- Colorectal cancer2 trials
- Endometrial cancer2 trials
- Ovarian cancer2 trials
- Bladder cancer1 trial
- Cervical cancer1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Kidney cancer1 trial
- Melanoma1 trial
- Pancreatic cancer1 trial
- and 1 more
- Phase
- Phase 12 trials
- Phase 1/22 trials
- Phase 21 trial
- Status
- Recruiting4 trials
- Active, not recruiting1 trial
- Lead sponsor
- Elevar Therapeutics1 trial
- Grey Wolf Therapeutics1 trial
- Pliant Therapeutics, Inc.1 trial
- Revolution Medicines, Inc.1 trial
- TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)1 trial
Running trials
Recruiting
A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement
Recruiting
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Recruiting
Recruiting
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer3 recruiting
- Colorectal cancer2 recruiting
- Endometrial cancer2 recruiting
- Liver and biliary tract cancer2 recruiting
- Ovarian cancer2 recruiting
- Bladder cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Kidney cancer1 recruiting
- Melanoma1 recruiting
- Pancreatic cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026